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Abstract Ferulic acid (FA) is a widely distributed
hydroxycinnamic acid found in various cereals and fruits
exhibiting potent antioxidant and anticancer activities.
However, due to low solubility and permeability, its
availability to biological systems is limited. Non-toxic
chitosan-tripolyphosphate pentasodium (CS-TPP)
nanoparticles (NPs) are used to load sparingly soluble
molecules and drugs, increasing their bioavailability. In the
present work, we have encapsulated FA into the CS-TPP
NPs to increase its potential as a therapeutic agent. Dif-
ferent concentrations of FA were tested to obtain optimum
sized FA-loaded CS-TPP nanoparticles (FA/CS-TPP NPs)
by ionic gelation method. Nanoparticles were characterized
by scanning electron microscopy, Fourier transformation
infrared spectroscopy (FTIR), thermogravimetric analyses
and evaluated for their anticancer activity against ME-180
human cervical cancer cell lines. The FTIR spectra con-
firmed the encapsulation of FA and thermal analysis
depicted its degradation profile. A concentration-dependent
relationship between FA encapsulation efficiency and FA/
CS-TPP NPs diameter was observed. Smooth and spherical
FA-loaded cytocompatible nanoparticles with an average
diameter of 125 nm were obtained at 40 lM FA conc. The
cytotoxicity of 40 lM FA/CS-TPP NPs against ME-180
cervical cancer cell lines was found to be higher as com-
pared to 40 lM native FA. Apoptotic morphological
changes as cytoplasmic remnants and damaged wrinkled
cells in ME-180 cells were visualized using scanning
electron microscopic and fluorescent microscopic tech-
niques. Data concluded that chitosan enveloped FA
nanoparticles could be exploited as an excellent therapeutic
drug against cancer cells proliferation.
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Introduction
Ferulic acid (FA) (4-hydroxy-3-methoxycinnamic acid) is
the most abundant hydroxycinnamic acid found in plant
cell walls forming covalent ester linkages to polysaccha-
rides and ether or ester linkages to lignin. It is reported to
have antioxidant, antimicrobial, anti-inflammatory,
cholesterol-lowering and anticancer activities, as well as
ability to prevent thrombosis and atherosclerosis (Wilson
et al. 2007; Akihisa et al. 2000; Ou et al. 1999; Kayahara
et al. 1999; Mori et al. 1999). Being capable of absorbing
UV radiations, FA is finding place as a photoprotective
constituent in many skin lotions and sunscreens (Saija et al.
2000). The strong antioxidant character of FA is attributed
to its unsaturated side chain and phenolic nucleus that
spontaneously forms resonance stabilized structures, thus
making it an effective antiproliferative agent. FA is a
dietary phytochemical that is known to possess antitumor
activities against several types of cancers such as colon,
gastric, breast and cervical cancers (Janicke et al. 2011;
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Kampa et al. 2004; Kyoungho et al. 2001). Approximately
500,000 cases of cervical cancer are diagnosed per year
making it the second leading cause of cancer mortality in
women following breast cancer (Ellenson and Wu 2004).
Radiotherapy is the major therapeutic technique to mini-
mize the effect of cervical cancer but due to its adverse
effect on normal tissues, alternative plant-derived thera-
peutic drugs are being tested increasingly (Seiwert et al.
2007). A large number of natural compounds have shown
cytotoxic effects in different cancer models either alone or
together with radiation (Garg et al. 2005). Effects of FA on
human cervical carcinoma cells ME-180 and HeLa have
been studied and indicated that FA treatment significantly
decreased radiation surviving fraction of the cancer cells
and increased the lipid peroxidation indices (Subburayan
et al. 2011).
Despite having valuable health benefits, bioavailability
and clinical efficacy of FA remain substantially limited
owing to its lower solubility and permeability in aqueous
medium as compared to other solvents such as ethanol,
acetone and dimethylsulphoxide (Munin and Le´vy 2011;
Soobrattee et al. 2005). Attempts have been made to
increase its solubility and bioavailability through encap-
sulation in biodegradable polymeric nanoparticles (Vemula
et al. 2006; Salmaso et al. 2007). Chitosan (CS), the
deacetylated form of chitin (2-amino-2-deoxy-(1-4)-D-
glucopyranan), exhibits excellent biodegradability, bio-
compatibility and antimicrobial activity (Liu et al. 2006);
thus, CS nanoparticles are extensively used to deliver
hydrophobic compounds including drugs, vitamins, pro-
teins, nutrients and phenolics into the biological systems
(Hu et al. 2008; Jang and Lee 2008). CS acts as a wall/shell
material to envelop these compounds bearing multiple
negative charges via cationic crosslinking to generate
stable, non-toxic, biodegradable nanosized particles
(Keawchaoon and Yoksan 2001). CS forms inter- and
intramolecular cross-linkages (called ionic gelation) when
comes in contact with specific polyanions such as
tripolyphosphate pentasodium (TPP) for drug encapsula-
tion (Sofia et al. 2008). Woranuch and Yoksan (2013)
studied the thermal stability of eugenol by encapsulation
into CS-TPP nanoparticles. Similarly, Sofia et al. (2008)
synthesized CS-TPP nanoparticles loaded with tea cate-
chins by the ionotropic gelation method.
To our best knowledge, present investigation is the first
report on in vitro antiproliferative potential of FA/CS-TPP
NPs against ME-180 human cervical cancer cell lines, their
encapsulation efficiency, loading capacity and particles
morphology. Physical states of native as well as encapsu-
lated FA were determined by thermal studies and the
interaction between active groups of chitosan nanoparticles




Low molecular weight chitosan (85 % deacetylation
degree), TPP, heat inactivated fetal calf serum (FBS),
glutamine, penicillin–streptomycin, EDTA and trypsin
were purchased from (Sigma Chemicals Co., St. Louis,
USA). FA, cell culture-grade dimethyl sulfoxide (DMSO),
acridine orange (AO), ethidium bromide (EtBr), Dul-
becco’s modified Eagle medium (DMEM) and all analyti-
cal grade chemicals were from Himedia (India). Human
cervical cancer ME-180 and Human Embryonic Kidney
(HEK-293) cell lines obtained from National Centre for
Cell Science (NCCS), Pune, India were used in this study.
Nanoparticles synthesis
Chitosan-TPP nanoparticles were prepared according to
earlier reported method with modifications (Woranuch and
Yoksan 2013). Briefly, chitosan solution (1 mg/ml) was
prepared by agitating chitosan flakes with aqueous acetic
acid (1 % v/v) solution at ambient temperature overnight.
Different concentrations (conc.) of TPP (0.125, 0.20, 0.25,
0.5, 1 mg/ml) were added slowly to the chitosan solution
with constant stirring to obtain CS-TPP nanoparticles with
optimum size properties. Nanoparticles were formed as a
result of interaction between the negative groups of TPP
and the positively charged amino groups of CS. For the
preparation of FA-loaded CS-TPP nanoparticles, FA was
added to the chitosan solution before TPP and effect of
varying FA conc. (5, 10, 20, 40 and 80 lM) was assessed
on loaded nanoparticles’ morphology.
Evaluation of ferulic acid encapsulation
and solubility
FA/CS-TPP NPs were centrifuged at 14,000 rpm for
30 min and the pellet was freeze-dried (Merlina et al.
2012). Supernatant was collected and the amount of non-
encapsulated FA was measured spectrometrically (Lasany
double beam LI-2800) at 319 nm. The percentage encap-
sulation efficiency (%EE) and loading capacity (%LC) of
FA were calculated using equations given below:
%EE ¼ Weight of initial FA loadedð
 weight of free FA/Weight of initial FA loadedÞ  100
%LC ¼ Weight of initial FA loadedð
 weight of free FA/Total weight of nanoparticlesÞ  100
Solubility of FA/CS-TPP NPs was tested by dissolving
1 mg of dried pellet in 1 ml acetic acid (1 % v/v) and water
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followed by vortexing it for 5 min. The mixtures were then
kept in a magnetic stirrer for 12 h and the percent
enhancement in solubility was recorded using native FA as
control.
Physicochemical characterization of nanoparticles
Morphology and size measurement
Field-emission scanning electron microscopy (FESEM;
Quanta 200F Model, FEI, Netherland) was used to
examine the morphology of nanoparticles by fixing them
onto glass slides and sputter coated (sputter coater:
Biotech SC005, Switzerland) with gold for 1 min. CS-
TPP as well as FA-loaded CS-TPP nanoparticles’ diam-
eters were measured over 50–100 different points of
FESEM images using image J analyzer software. Zeta
potential values of the synthesized nanoparticles were
recorded using Zetasizer (Malvern Nano ZS; Malvern
Instruments Ltd, UK).
Fourier transformation infrared spectroscopy
The Fourier transform infrared (FTIR) spectra of the
nanoparticles were analyzed by an IR spectrometer (FTIR;
Thermo Nicolet Nexus 6700, US). Average values of 32
scans were recorded with 4000–400 cm-1 wavelength
scanning range and resolution of 4 cm-1 for each sample.
Thermogravimetric and derivative thermogravimetric
analyses
Thermogravimetric and derivative thermogravimetric
analyses of native FA and nanoparticles preparations (CS-
TPP, FA/CS-TPP NPs) were performed in a simultaneous
DTA-TG Apparatus (EXSTAR, TG/DTA 6300). Samples
(2–8 mg) were heated from 20 to 500 C at a scanning rate
of 10 C/min. Nitrogen was used as the purge gas at a flow
rate of 20 ml/min.
Analysis of anticancer potential
ME-180 cells were maintained in McCoy’s modified
medium supplemented with 10 % FBS, 1 % glutamine,
100 U/ml penicillin and 100 lg/ml streptomycin at 37 C
in 5 % CO2 atmosphere. Cells (3 9 10
4/well) were seeded
in 96-well plates and treated with 10 lL of each formula-
tions; native FA (5, 10, 20, 40 and 80 lM), CS-TPP and
FA/CS-TPP NPs followed by MTT assay at 540 nm (Ky-
oungho et al. 2001). Untreated cells growing in culture
media only were taken as control. The cell viability was
calculated as:
Cell viability %ð Þ ¼ OD540nm test samplesð Þ=OD540nm controlð Þ
 100
Visualization of apoptotic morphological changes
The control, native FA and FA/CS-TPP NPs treated cells
were seeded in 6-well plate (3 9 104/well) and incubated
in CO2 incubator for 24 h. The cells were immediately
washed in PBS and observed using inverted phase contrast
microscope (CarlZeiss, Axiovert 25, Germany). For
FESEM analysis, cancer cells were fixed onto glass slide
by 2.5 % glutaraldehyde PBS solution for 4 h and visual-
ized. For further validation of apoptotic morphological
changes, the cells were dual stained with acridine orange
(AO) and ethidiumbromide (EtBr) in 1:1 ratio and visual-
ized using fluorescent microscope (CarlZeiss, Axiovert 25,
Germany).
Cytocompatibility evaluation
Each test formulation (40 lM native FA, unloaded CS-TPP
NPs and 40 lM FA/CS-TPP NPs) was tested for its cyto-
compatibilty by means of HEK-293 cells using a previ-
ously described protocol (Vashisth et al. 2015). Untreated
cells were used as control; MTT assay and FESEM anal-
ysis (as described for ME-180 cells) were carried out fol-
lowing 24 h of cell seeding.
Statistical analysis
All measurements were performed in three independent
experiments; data were expressed as mean value ±standard
deviation. The significance of differences (p\ 0.05)
among the corresponding mean values was determined
using one-way analysis of variance (ANOVA).
Results and discussion
Nanoparticles synthesis, morphology
and encapsulation of ferulic acid
The ratio between CS and TPP is critical in controlling the
size as well as size distribution of NPs thereby affecting
their biological performance (Pan et al. 2002). Different
concentrations of TPP were used to find the optimum CS-
TPP ratio so as to obtain nanoparticles with narrow size
distribution, before the FA encapsulation. CS-TPP weight
ratio of 5/1 produced most compact nanoparticles with
zeta potential value 44.2 meV and average particle diam-
eter of 57.5 ± 27.6 nm. FESEM images of CS-TPP NPs at
5/1 weight ratio and their corresponding size distribution
histogram are presented in Fig. 1. This ratio of 5/1 was
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selected for the preparation of FA-loaded nanoparticles.
The average particle diameter of FA/CS-TPP NPs at
varying FA concentrations along with their EE and LC is
summarized in Table 1. Data showed that with increase in
initial FA concentration EE also increased and reached to
a maximum of 63.0 ± 2.20 % with 40 lM FA. Similarly,
LC also tended to increase as a function of initial FA
content ranging from 4.4 ± 1.3 to 32.9 ± 2.1 %. At
80 lM, a reduction in EE was observed while LC at this
conc. remained almost equivalent to 40 lM which could
have occurred due to encapsulation limitation of chitosan
at higher FA conc. The results obtained were in agreement
with previous literature that reported encapsulation and
loading of phenolic compound carvacrol into chitosan
nanoparticles (Keawchaoon and Yoksan 2001). At 40 lM
FA conc. smooth and spherical FA-loaded nanoparticles
with positive zeta potential value ±22.5 meV and average
particle diameters of 125 nm (polydispersity index value
=0.41) were obtained (Fig. 2). Since no intercalated
deposition of FA crystals was observed, it could be
inferred that there was a uniform distribution of FA inside
the CS-TPP NPs. The solubility of FA/CS-TPP NPs at
40 lM was enhanced approximately by 28 and 25 % in
water and 1 % acetic acid (v/v), respectively, at room
temperature. The observed enhancement in solubility may
be attributed the combined effect of interfacial adsorption
and enhanced bioavailability of FA in the aqueous phase
following encapsulation within CS. Interaction of phenolic
phytochemicals with hydrophobic sites of nanoparticles
through hydrogen bonds and hydrophobic forces is well
established. Sufficient surface charges and suitable hydra-
tion property keep phenolic phytochemical encapsulated
nanoparticles stable in aqueous system, which enhances
the water solubility of phenolic phytochemicals (Li et al.
2015). Significant decrease in zeta potential value of CS-
TPP NPs upon FA encapsulation from approximately ?44
Fig. 1 FESEM micrographs of CS-TPP NPs (5/1 wt ratio) along with their diameter distribution histogram. Microscopic magnification 9100 K,
Scale bar 100 nm. SD standard deviation, n = 3; AD average diameter
Table 1 Average nanoparticles
diameter, encapsulation
efficiency and loading capacity
of different test formulations
FA/CS-TPP (lM FA) NPs Avg Dia (nm) EE of FA (%) LC of FA (%)
CS-TPP (5/1) 57.5 ± 27.6 – –
FA/CS-TPP (5) 48.3 ± 13.8 – –
FA/CS-TPP (10) 67.4 ± 23.4 11.5 ± 1.41 4.4 ± 1.3
FA/CS-TPP (20) 89.3 ± 14.6 29.0 ± 3.11 11.3 ± 0.9
FA/CS-TPP (40) 125 ± 44.7 63.0 ± 2.20 32.5 ± 3.4
FA/CS-TPP (80) 1000–2000 34.2 ± 4.11 32.9 ± 2.1
FA ferulic acid, NPs nanoparticles, EE encapsulation efficiency, LC loading capacity, FA/CS-TPP ferulic
acid-loaded chitosan-tripolyphosphate pentasodium, Avg average, Dia diameter
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to ?22 meV was observed. Zeta potential of a nanoparti-
cle system expresses its stability in suspension through
electrostatic repulsion between individual particles (Lee
et al. 2010). So, the decrease in zeta potential of above two
formulations could be in part attributed to the retardation
of electrophoretic mobility of the nanoparticles as a result
of their size enhancement upon FA encapsulation. Neu-
tralization of some of the positive surface charges of CS-
TPP NPs might have also occurred due to adsorption of
FA onto nanoparticles surface. Similar reduction in the
zeta potential and subsequent size enhancement in
L-ascorbic acid-loaded chitosan nanoparticles were
reported earlier (Jang and Lee 2008). At 10 lM FA con-
centration, smaller particles bound together to form ran-
dom clusters were observed (Supplementary Fig. 1).
However, at higher FA concentration (80 lM), crystalline
particles in the size range of 1–2 lm were detected
(Supplementary Fig. 2). Thus, from the data obtained it
was concluded that 40 lM conc. of FA was optimum to
obtain fairly spherical and evenly distributed FA/CS-TPP
NPs with a higher encapsulation efficiency for the present
work.
Fourier transformation infrared spectroscopy
analysis
To study various secondary interactions (hydrogen bonding,
hydrophobic interactions and electrostatic forces) between
the active groups of encapsulated FA and CS-TPP, FTIR
spectra were analyzed. Characteristic peaks of native FA
were observed at 3436 cm-1 (–OH stretching), 2249 cm-1
(C–H bond stretching), 1568, 1411 cm-1 (C=C aromatic
ring) as shown in Fig. 3a. The data were in accordance with
the FTIR peaks reported earlier for FA (Ronald 2012). The
FTIR spectra of cross-linked CS-TPP and FA/CS-TPP NPs
are shown in Fig. 3b. For CS-TPP nanoparticles, a charac-
teristic band at 3394 cm-1 is attributed to –NH2 and –OH
groups stretching vibration, 1636 (amide II), 1384 cm-1
(C3–O) and 1073 cm
-1 (C6–O) as reported earlier (Vimal
et al. 2013). For FA/CS-TPP NPs, increased peak intensity
at each bond stretching resulted in shifting of peak values. A
new peak was observed at 2437 cm-1, while the peaks at
3394 and 549 cm-1 were shifted to 3225 and 651 cm-1,
respectively, due to hydrogen bonding between –OH and
NH3
? group of CS and –OH and –C=O active groups of FA
(Sofia et al. 2008; Liu et al. 2013). The presence of common
peak at 1411 cm-1 corresponding to C=C aromatic ring in
both native FA and FA/CS-TPP indicates their interaction.
Also, the band at 3436 cm-1 in case of native FA has been
broadened and shifted to 3225 cm-1 signifying a possible
O–H–O bonding occurring between native FA and FA/CS-
TPP. The FTIR spectra analyses thus indicate the formation
of a copolymer, suggesting the successful loading of FA
into the CS-TPP nanoparticles (Fig. 3c).
Thermogravimetric and derivative
thermogravimetric analyses
Thermal properties of samples were determined by ther-
mogravimetric analysis (TGA) to investigate the mass loss
of a sample upon heating at a given heating rate. The TGA
curves of FA, CS-TPP and FA/CS-TPP NPs are shown in
Fig. 4a. FA exhibited a single stage weight loss, with
decomposition starting at 173 C, while CS-TPP NPs
exhibited decomposition in two stages. An initial weight
loss of CS-TPP NPs between 150 and 250 C may be
attributed to dehydration of the saccharide rings, while the
second stage decomposition ranging from 275 to 450 C
resulted from complex processes including depolymeriza-
tion and decomposition of the acetylated and deacetylated
units of polymer (Sindhu and Abraham 2008). Similarly for
FA-loaded CS-TPP, the initial weight loss was observed at
80–100 C due to evaporation of water. Major weight loss
started at approximately 200 C and continued linearly up
to 500 C. The decrease in decomposition temperature of
FA/CS-TPP NPs, over unloaded CS-TPP NPs might be due
Fig. 2 FESEM micrographs of FA-loaded CS-TPP NPs (40 lM FA)
along with their diameter distribution histogram. Microscopic mag-
nification 9100 K, Scale bar 100 nm. SD standard deviation, n = 3;
AD average diameter
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to the reduction in crystalline structure of CS following FA
encapsulation. However, this reduction in decomposition
temperature had negligible effect on stability and integrity
of FA-loaded nanoparticles structure as indicated by
derivative thermogravimetric analyses (Fig. 4b). The ther-
mogravimetric analyses thus indicated that FA could be
successfully loaded into CS-TPP nanoparticles, to increase
its thermal resistance.
Fig. 3 FTIR spectra a FA, b CS-TPP and c FA-loaded chitosan-TPP nanoparticles
Fig. 4 Thermograms of native FA, CS-TPP NPs and FA-loaded CS-TPP NPs a TGA, b DTG
808 Appl Nanosci (2016) 6:803–813
123
The derivative thermogravimetric analyses of the FA
and CS-TPP nanoparticles showed peak maximum
decomposition at 247 and 272 C, respectively; while FA-
loaded CS-TPP nanoparticles exhibited decomposition
temperatures approximately at 220, 290 and 430 C
(Fig. 4b). The distribution of peak maxima in encapsulated
FA may be a result of its interaction with polymeric
components of CS.
In vitro cytotoxicity analysis
ME-180 cervical cancer cell lines were tested for growth
inhibition under different formulations, viz., 20 lM native
FA (FA1), 40 lM native FA (FA2), unloaded CS-TPP
NPs, 20 lM (NP1) and 40 lM FA/CS-TPP (NP2) keeping
untreated cells as control (Fig. 5). As indicated, 40 lM
FA/CS-TPP NPs caused maximum inhibition (57 %) of
cell proliferation as compared to other formulations, this
concentration was also found to yield most stable formu-
lation of encapsulated nanoparticles. Previous studies on
FA-treated ME-180 cervical cancer cell lines have indi-
cated increased intracellular ROS levels along with inhi-
bition of cell growth, increased lipid peroxidation and
profound induction of cell apoptosis, in combination with
gamma radiations (Subburayan et al. 2011). Literature
reports that chitosan nanoparticles owing to their positive
surface charges adsorb with a high affinity onto the neg-
atively charged tumor cell membrane (Qi et al. 2005). In
the present investigation, FA/CS-TPP NPs would have
bind to the tumor cell membrane via electron interactions,
entered the cell through endocytosis and release the
encapsulated FA into cytosol (endosomal burst). Due to
increased bioavailability, FA exhibits its antitumor effect
by influencing the mitochondrial activity and antioxidant
status of the cell disrupting the cell organelle which would
eventually lead to cell death. In our earlier reports, FA
from Parthenium hysterophorus and FA encapsulated
nanofibers were found to exhibit anticancer potential
against different cell lines (Panwar et al. 2015, Vashisth
et al. 2015). Zhou et al. (2007) reported the 27 %
Fig. 5 MTT viability assay for ME-180 cells treated with different
test formulations after 24 h at 540 nm. Error bars represent
mean ± standard deviation for three independent experiments
(n = 3), *p\ 0.05 indicates statistical significant difference as
compared to control
Fig. 6 ME-180 cell lines showing morphological effects through
phase contrast micrographs and its corresponding scanning electron
micrographs (a, e) control cells (b, f) cells treated with 40 lM native
FA (c, g) cells treated with CS-TPP NPs (d, h) cells treated with
40 lM FA-loaded CS-TPP NPs upon 24 h of incubation. Scale bar
10 lm, microscopic magnification 910 K
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inhibition of HeLa cervical cancer cell lines when treated
with 500 mg/L chitosan nanoparticles. Decrease in mito-
chondrial membrane proteins by chitosan nanoparticles
has also been reported earlier (Qi et al. 2005). From our
data it could be inferred that 40 lM FA/CS-TPP NPs
displayed an enhanced cytotoxicity against ME-180 cer-
vical cancer cell lines which could be attributed to the
synergistic effect of both FA and CS-TPP NPs causing the
disruption of cancer cell membrane integrity and mito-
chondrial damage.
Apoptotic morphological changes
To observe the cytotoxic effect of different formulations on
cell morphology, the cells were examined by phase contrast
and scanning electron microscopy. Data showed that the
Fig. 7 Fluorescent micrographs of AO:EtBr stained ME-180 cells
(A1–A3) control cells (B1–B3) CS-TPP NPs treated (C1–C3) 40 lM
native FA treated (D1–D3) FA/CS-TPP NPs treated after 24 h
incubation. Morphological signs such as chromatin condensation
and damaged wrinkled cells are marked with white arrows. Micro-
scopic magnification 9100 K
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cells treated with 40 lM FA/CS-TPP NPs for 24 h dis-
played morphological characteristics such as higher cell
shrinkage, cytoplasmic condensation, and irregularity in
shape, suggesting that FA-loaded chitosan nanoparticles
induce apoptotic cell death in the ME-180 cells (Fig. 6d,
h). The morphology and growth of cancer cells cultured on
unloaded CS-TPP NPs were only negligibly affected as
compared to control (Fig. 6c, g). Significant reduction in
cancer cell number/growth was observed in the FESEM
micrographs in the cells treated with FA/CS-TPP NPs
(Fig. 6h). To further confirm the induction of apoptosis,
treated cells were visualized by fluorescence microscopy
following treatment with 1:1 ratio of AO/EtBr, which allow
differentiation of dead and viable cells by staining DNA.
Cells with intact membranes fluoresce green due to AO
staining while EtBr stains cells with damaged membranes
which exhibit orange fluorescence due to DNA intercala-
tion of both stains. As depicted in Fig. 7, ME-180 cells
treated with unloaded CS-TPP NPs did not show any
retardation of cell proliferation, similar to control cells. On
the other hand, cells treated with native FA and FA/CS-
TPP NPs have undergone considerable damage. Morpho-
logical signs such as chromatin condensation and damaged
wrinkled cells indicated encapsulated FA-induced apopto-
sis to destroy cancer cells (Fig. 7D3). Results obtained
suggested the role of CS-TPP NPs in guiding the encap-
sulated FA more precisely towards a physiological target
hence complementing to generate stronger and more effi-
cient antiproliferative action of FA/CS-TPP NPs as com-
pared to native FA. Earlier literature reported the antitumor
and antiproliferative nature of encapsulated FA in bio-
compatible polymers against different cell lines and dose-
dependent apoptosis of cancer cells treated with chitosan
nanoparticles leading to cell death induction (Sofia et al.
2008; Woranuch and Yoksan 2013; Qi et al. 2005).
Cytocompatibility evaluation
To verify the potential applications of FA-loaded
nanoparticles as a clinical therapeutic against cancer cells,
its cytocompatibility was tested on HEK-293 cells. Sur-
face morphology of the cells seeded on native FA and FA/
CS-TPP NPs are presented in Fig. 8. Negligible changes
in cell adherence and morphology could be visible in the
cells treated with FA/CS-TPP NPs (Fig. 8c) as compared
to control cell’s matrix (Fig. 8a). In contrast, complete cell
disruption and significant change in surface morphology
were observed (Fig. 8b) for cells treated with 40 lM
native FA which may be attributed to its free radical
scavenging ability (Ou and Kwok 2004). Studies have
revealed that phenolic compounds such as FA at higher
concentrations may act as pro-oxidant interacting with
transition metal ions found in biological systems which
lead to oxidative damage of normal cellular components
(Maurya and Devasagayam 2010; Galati and O’Brien
2004). Our research group too has reported that the via-
bility of non-cancerous HEK-293 cell lines was lower in
presence of native FA in comparison with the nanofiber
encapsulated FA (Vashisth et al. 2015). Data obtained in
our investigation imply superior cytocompatibilty of FA/
CS-TPP NPs as compared to native FA at the same con-
centration (40 lM).
Fig. 8 SEM micrographs of HEK-293 cells (a) control (b) cell treated with 40 lM native FA (c) cells treated with 40 lM FA-loaded CS-TPP
NPs incubated for 24 h. Scale bar 1 lm, microscopic magnification 925 K
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Conclusions
In this study, we encapsulated FA into CS-TPP nanopar-
ticles to develop a polymeric nanocarrier with enhanced
thermal degradation range. Secondary interactions of FA
with CS-TPP nanoparticles were studied using FTIR,
suggesting its successful encapsulation. Analyses of
nanoparticles morphology indicated the formation of
smooth and fairly spherical FA/CS-TPP NPs, with high
encapsulation efficiency. MTT assay revealed strong
antiproliferative activity of FA-loaded chitosan-TPP
nanoparticles due to apoptotic induction as shown by
morphological analyses. The results so obtained suggest
that the encapsulation of FA into CS-TPP nanoparticles
may enhance its cytocompatibilty, solubility and anticancer
potential against ME-180 cell lines, thereby presenting it as
a potent therapeutic agent for medicine and clinical usage.
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